Physician profile
Wissam Fawzi Ali
NPI 1396845558
$2,026.67
in general payments reported to CMS, 2019-2025
9 companies · $167 in 2025
The $167 reported for 2025 was more than what 78% of Dental Anesthesiology providers received nationally (typical 2025 total: $50.33).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.71 · 2020: $479 · 2021: $303 · 2022: $93.16 · 2023: $65.55 · 2024: $902 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $564 · Food and Beverage: $455 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $564.41 |
| Food and Beverage | $455.23 |
| Education | $115.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,065.56 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $425.00 | 2020 | |
| Acteon INC | $275.00 | 2021 | |
| Zimvie INC. | $67.83 | 2024 | |
| Colgate Oral Pharmaceuticals, INC. | $65.55 | 2023 | |
| Implant Direct Sybron International LLC | $46.12 | 2019-2022 | |
| Philips North America LLC | $42.28 | 2020 | |
| Salvin Dental Specialties, INC. | $28.09 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wissam Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.